Voyageur Pharmaceuticals Ltd. News

Voyageur Pharmaceuticals Ltd. Announces Closing of Over Subscribed $1Million Private Placement and Issuance of Shares for Debt

June 16, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) is pleased to announce that, further to its […]


Voyageur Pharmaceuticals Ltd. Announces Increase to Proposed Private Placement

May 31, 2022 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce that, further to its […]


Voyageur Pharmaceuticals Ltd. Announces Proposed Private Placement

May 26, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce that it plans […]


Voyageur Pharmaceuticals Completes Milestone with the FDA and Continues to Move Towards Commercialization on Three Fronts

May 18, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (“Voyageur” or the “Company”) (TSXV:VM) is pleased to announce that it is progressing with […]


Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and Debt

May 10, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) has agreed to pay deposits for work on […]


Voyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment Report

February 24, 2022 (Source) — Voyageur Pharmaceuticals Ltd. (“Voyageur” or the “Company”) (TSXV:VM) (OTC:VYYRF) is pleased to announce the filing of its Preliminary […]